Cefotax

Composition

Each vial contains: 

Cefotaxime sodium …………………………………………….. 262.5 mg, 525 mg, 1050 mg, or 2100 mg

Equivalent to cefotaxime ………………………………………………………. 250 mg, 500 mg , 1 g, or 2 g

Each solvent ampoule contains: 

Water for injection …………………………………………………………………………… 2 ml , 5 ml, or 10 ml

Therapeutic Indications

CEFOTAX is indicated in the treatment of serious infections, either before the infecting organism has been identified or when caused by bacteria of established sensitivity, including: 

Osteomyelitis.

Septicaemia.

Bacterial endocarditis.

Meningitis.

Peritonitis.

Other serious bacterial infections suitable for parenteral antibiotic therapy.

CEFOTAX may be used for pre-operative prophylaxis in patients undergoing surgical procedures, that may be classified as contaminated or potentially so.